Comparing surgical methods for metastatic pathologic fractures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the short-term outcomes of three surgical interventions—endoprosthetic reconstruction, intramedullary nailing, and open reduction internal fixation—for patients with metastatic pathologic fractures. Conducted at Ankara University, the study will assess factors such as the primary tumor type, chemotherapy and radiotherapy history, and various risk scores to determine the most effective surgical approach. The goal is to relieve pain and facilitate early mobilization in patients suffering from these fractures, which often require surgical intervention rather than conservative treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* metastatic pathologic fracture
* operated via endoprosthesis, intramedullary nail or plate \& screws

Exclusion Criteria:

* primary bone tumor
* conservative management
* neuromuscular disease
* periprosthetic fractures
* less than 1 month follow up

Where it's running

• Ankara University Medical Faculty
  Ankara, altindag, Turkey (Türkiye) Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• IL-15–Enhanced NK Cell Therapy for Solid Tumors

  A first-in-human, early-phase study tests whether IL-15–enhanced engineered NK cells are safe and can show early signs of effect in adults with relapsed or metastatic solid tumors.

  Recruiting Early Phase 1 Genovn Therapeutics PTE. LTD. · Chongqing · NCT07621471

• LATTICE radiotherapy vs moderately dose-escalated palliative radiation for metastases

  This study tests whether LATTICE radiotherapy given in 5 fractions works better than a standard palliative dose for patients with metastatic cancer who have 1–2 sizable tumors.

  Recruiting Phase 2 Stanford University · Palo Alto, California · NCT07594431

• Prophylactic Radiotherapy to Prevent Bone Complications in Metastatic Cancers

  This study tests whether giving early radiotherapy to high-risk bone metastases, in addition to standard care, can reduce bone-related problems in adults with metastatic solid cancers.

  Recruiting Phase 2 Institute of Oncology Ljubljana · Ljubljana · NCT07540650

• Givastomig with nivolumab and chemotherapy for CLDN18.2-positive metastatic stomach or gastroesophageal junction cancer

  This study will see if adding givastomig to nivolumab plus standard chemotherapy helps adults with CLDN18.2- and PD-L1-positive metastatic stomach or gastroesophageal junction cancer live longer without their disease getting worse.

  Recruiting at 5 sites Phase 2 I-Mab Biopharma US Limited · Goodyear, Arizona and 5 other locations · NCT07432295

• Focused high-dose SBRT for spinal tumors

  This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.

  Recruiting at 2 sites Institute of Oncology Ljubljana · Ljubljana and 1 other locations · NCT07429422

• Registry for people with symptomatic bone metastases

  This registry collects health information from adults with symptomatic bone metastases who need treatment for painful or unstable bone lesions to learn more about outcomes and care.

  Recruiting at 7 sites Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07391410

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.